McQueen Ball & Associates’s Pfizer PFE Stock Holding History

McQueen Ball & Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$2.59M	Hold	62,443	–	–	1.66%	17
2018 Q3	$2.61M	Hold	62,443	–	–	1.48%	19
2018 Q2	$2.15M	Sell	62,443 -1,663	-3%	-$56.8K	1.3%	25
2018 Q1	$2.16M	Buy	64,106 +231	+0.4%	+$7.94K	1.32%	24
2017 Q4	$2.19M	Hold	63,875	–	–	1.32%	25
2017 Q3	$2.16M	Buy	63,875 +2,872	+5%	+$92.3K	1.39%	24
2017 Q2	$1.94M	Buy	61,003 +657	+1%	+$20.7K	1.28%	27
2017 Q1	$1.96K	Sell	60,346 -258	-0.4%	-$8.13K	1.07%	24
2016 Q4	$1.87M	Sell	60,604 -411	-0.7%	-$12.5K	1.25%	25
2016 Q3	$1.96M	Sell	61,015 -535	-0.9%	-$17.9K	1.34%	22
2016 Q2	$2.06M	Buy	61,550 +379	+0.6%	+$12.1K	1.46%	19
2016 Q1	$1.72M	Sell	61,171 -1,255	-2%	-$35.8K	1.27%	27
2015 Q4	$1.91M	Buy	+62,426	New	+$1.96M	1.73%	15

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

McQueen Ball & Associates's PFE Position: Q4 2018 in Review

McQueen Ball & Associates held its Pfizer (PFE) position steady in Q4 2018 at 62,443 shares worth $2.59M. The position accounts for 1.66% of the portfolio, ranked #17.

McQueen Ball & Associates first reported a position in PFE in Q4 2015 and has held it in 13 quarters since. The position peaked at $2.61M in Q3 2018. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

McQueen Ball & Associates held 62,443 shares of Pfizer worth $2.59M as of Q4 2018.
McQueen Ball & Associates left its Pfizer share count unchanged in Q4 2018.
Pfizer made up 1.66% of McQueen Ball & Associates's portfolio in Q4 2018, its #17 holding.
McQueen Ball & Associates first reported a position in Pfizer in Q4 2015 and has held it in 13 quarters since.
McQueen Ball & Associates's Pfizer position peaked at $2.61M in Q3 2018.
2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on McQueen Ball & Associates's 13F filing for Q4 2018, filed 3 Jan 2019.